CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim
Endocrinol Metab. 2021;36(1):157-170.   Published online February 24, 2021
DOI: https://doi.org/10.3803/EnM.2020.781

Excel Download

Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
Endocrinology and Metabolism. 2021;36(1):157-170   Crossref logo
Link1 Link2 Link3

Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes
Endocrinology and Metabolism. 2021;36(1):57-59   Crossref logo
Link1 Link2 Link3

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
Diabetes mellitus. 2018;21(4):293-300   Crossref logo
Link1 Link2

Potential therapies mimicking the effects of glucagon-like peptide-1 for the treatment of Type 2 diabetes
Diabetic Medicine. 2004;21(s1):18-20   Crossref logo
Link1 Link2

Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes
Diabetes, Obesity and Metabolism. 2017;19(5):613-614   Crossref logo
Link1 Link2

Glucagon-like Peptide-1 Analogue and Dipeptidyl Peptidase-IV Inhibitors
Journal of Korean Endocrine Society. 2006;21(6):437   Crossref logo
Link1 Link2 Link3

Emerging incretin (glucagon-like peptide-1)-derived therapies for type 2 diabetes
Diabetes, Obesity and Metabolism. 2008;10:1-1   Crossref logo
Link1 Link2

Glucagon-like peptide-1 in type 2 diabetes: the -cell and beyond
Diabetes, Obesity and Metabolism. 2008;10:2-13   Crossref logo
Link1 Link2

Effects of body weight reduction on plasma fibroblast growth factor 21 in obese patients with type 1 diabetes mellitus
Atherosclerosis. 2015;241(1):e178-e179   Crossref logo
Link1 Link2

Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model
International Journal of Molecular Sciences. 2020;21(18):6836   Crossref logo
Link1